SavedAdd your journal

Journals / Medicine Science / 2017 / Cilt: 6 - Sayı: 3

Evaluation of oxidative stress factors in patients with osteoporosis

HACİ AHMET DEVECİ
GÖKHAN NUR
HÜLYA ÇİÇEK
MAHMUT KARAPEHLİVAN
Pages
479–482
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Also, higher plasma sialic acid levels in the patients with osteoporosis may be caused by increasing in of sialic acid secretion from the cell membrane surface that based on oxidative tissue damage

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Osteoporosis is an important disease with an increasing incidence that leads to serious losses in physical function and adversely affecting the life quality of women especially in postmenopausal period.
📊
Key Findings & Data:Therefore, we aimed to investigate the plasma paraoxonase (PON1) activity, highdensity lipoprotein (HDL), total sialic acid (TSA) and total oxidant/antioxidant status (TOS/TAS) of patients with osteoporosis in this study.
💡
Conclusion & Impact:Also, higher plasma sialic acid levels in the patients with osteoporosis may be caused by increasing in of sialic acid secretion from the cell membrane surface that based on oxidative tissue damage
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Osteoporosis is an important disease with an increasing incidence that leads to serious losses in physical function and adversely affecting the life quality of women especially in postmenopausal period. Age, genetic structure, vitamin D and K abnormalities, estrogen deficiency, chronic inflammation and oxidative stress are considered among the most important risk factors for osteoporosis. Therefore, we aimed to investigate the plasma paraoxonase (PON1) activity, highdensity lipoprotein (HDL), total sialic acid (TSA) and total oxidant/antioxidant status (TOS/TAS) of patients with osteoporosis in this study. Comparisons of 25 female patients diagnosed with osteoporosis aged between 51-67 and 10 healthy women between the ages ranged 50-68 were made in this study. PON1 activity, HDL, TSA, TOS and TAS levels were measured by spectrophotometrical method in plasma samples that obtained from blood samples of patients and healthy individuals. Results were expressed as mean ± standard deviation. Plasma PON1 activity, TAS and HDL levels were significantly lower in patiens with osteoporosis than the healty group (p<0.001, p<0.001 and p<0.01 respectively). Also, plasma TSA and TOS levels were higher in patients with osteoporosis compared to the healthy group were found statistically significant (p<0.01). Increased reactive oxygen species in patients with osteoporosis may play an important role by causing oxidative stres in the pathogenesis of osteoporosis. Based on oxidative stres, increasing levels of oxidant and reducted levels of antioxidant molecules indicates that may be an important indicator of bone loss in women. Also, higher plasma sialic acid levels in the patients with osteoporosis may be caused by increasing in of sialic acid secretion from the cell membrane surface that based on oxidative tissue damage

🔖

Cite This Article

DEVECİ, H. A., NUR, G., ÇİÇEK, H., KARAPEHLİVAN, M. (2017). Evaluation of oxidative stress factors in patients with osteoporosis. Medicine Science, Cilt: 6 - Sayı: 3, 479–482. https://ajindex.com/articles/277420

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Kanis JA. Osteoporosis and its consequences. in: Kanis JA eds, Osteoporosis. BlackwelJ Science Ltd. London. 1997;21
  2. Biberoğlu S. Pathogenezis of osteoporosis. Kutsal Y.G. Osteoporoz. 2nd edition. Ankara/Turkey: Güneş. 2005;37-60
  3. Akıncı A, Bartl R, Frisch B. Osteoporosis. 1st eds. Ankara: Turkish Clinics. 2006;1-24
  4. Merly SL. Metabolic bone diseases. in: Kelley WH, Harris ED, Ruddy S, Sledge CB, eds, Textbook of Rheumatology. WB Saunders Company, Philadelphia. 1997;563-1581
  5. Ersler WB, Harman SM, Keller ET. Immunologic aspects of osteoporosis. Dev Comp Immunol. 1997;21(6):487-99
  6. Çavdaroğlu B, Köse N, Başkol G, Demir H. Postmenopozal osteoporozlu hastalarda proteinler ve lipidlerdeki oksidatif stresin değerlendirilmesi. Dicle Tip Fakul Derg. 2014;41(1):71-77
  7. Yang S, Ries WL, Key LL. Nicotinamide adenine dinucleotide phosphate oxidase in the formation of superoxide in osteoclasts. Calcif Tissue Int. 1998;63(4):346-50
  8. Kutlu R, Çivi S, Pamuk G. Postmenopozal kadınlarda osteoporoz sıklığı ve FRAXTM Skalası kullanılarak 10 yıllık kırık riskinin hesaplanması. Türk Fiz Tıp Rehab Derg. 2012;58:126-35
  9. Tabakoğlu E,, Durgut R. Veteriner hekimlikte oksidatif stres ve bazı önemli hastalıklarda oksidatif stresin etkileri. AVKAE Derg. 2013;3(1):69-75
  10. Basu S, Michaelsson K, Olofsson H, Johansson S, Melhus H. Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun. 2001;288(1):275-9
  11. Sontakke AN, Tare RS. A duality in the roles of reactive oxygen species with respect to bone metabolism. Clin Chim Acta. 2002;318(1-2):145-8
  12. Madenci E, Güçbey Ş, Koca I, Ibas E, Çiçek H. Serum total oxidative and antioxidative status in patients with postmenopausal osteoporosis. Nobel Medicus. 2015;11(1):83-86
  13. Eckerson HW, Romson J, Wyte CM, La Du BN. The human serum paraoxonase polymorphism: Identification of phenotypes by their response to salts. Am J Hum Genet. 1983;35(2):214-27
  14. Gülcü F, Gürsu MF. Paraoksonaz ve aril esteraz aktivite ölçümlerinin standardizasyonu. Turk J Biochem. 2003;28:45-9
  15. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable abts radical cation. Clin Biochem. 2004;37(4):277-85
  16. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38(12):1103-11
  17. Sydow G. A simplifield quick method for determination of sialic acid in serum. Biomed Biochem Acta. 1985;44(11-12):17